Marketed in 30 countries across Europe, the Americas, Asia, and Oceania, Seroquel XR is an internationally distributed extended-release brand of quetiapine, classified as an antipsychotic within the broader psycholeptic and psychoanaleptic categories. This page is written for travellers, expatriates, and family members trying to identify the medication abroad or recognise it on a local prescription.
Quetiapine is prescribed in the management of several psychiatric conditions, including schizophrenia, bipolar disorder, psychosis, and clinical depression. The extended-release format positions Seroquel XR specifically within long-term maintenance regimens for these indications, and the structured indication list further down this page details the registered uses recognised in each market where the product is sold.
Because Seroquel XR is registered across a wide regulatory spread, travellers and expatriates regularly encounter it abroad — sometimes under the Seroquel XR label, sometimes as a quetiapine-containing generic. Markets where it is registered include Canada, Australia, Argentina, Hong Kong, and Israel, but national packaging, prescription rules, and the availability of extended-release versus immediate-release formulations vary considerably. A local pharmacist is usually the right first point of contact for confirming whether a quetiapine product on a foreign shelf corresponds to what the patient is used to.
Other medications within the antipsychotic class are also distributed internationally under different molecules and brand names, but they are not interchangeable on a like-for-like basis — the choice of agent is a clinical one. Anyone taking Seroquel XR, considering it, or trying to identify a comparable preparation in another country should treat substitution as a decision for their healthcare provider, with a local pharmacist available to clarify regional brand names.